IceCure's Advanced Multiprobe Cryoablation Technology Receives Patent Approval in Japan
November 25, 2024 - 22:01
IceCure Medical Ltd. has announced that its next-generation multiprobe cryoablation technology has received a Notice of Allowance from Japan's Patent Office. This significant development marks a key milestone for the company's innovative approach to minimally invasive medical procedures.
The multiprobe cryoablation technology is designed to enhance the effectiveness and efficiency of cryoablation treatments, which are used to destroy abnormal tissues through extreme cold. This advancement is expected to provide physicians with improved tools for treating various medical conditions, potentially leading to better patient outcomes.
The approval from Japan's Patent Office underscores the technological advancements that IceCure is bringing to the field of cryoablation, positioning the company for growth in the competitive medical technology market.
MORE NEWS
April 19, 2026 - 07:31
Is It Too Late To Consider Align Technology (ALGN) After Recent Share Price Rebound?After a significant rebound, investors are questioning whether Align Technology`s stock still holds potential or if the window for substantial gains has closed. The company`s share price, now...
April 18, 2026 - 17:13
How The GigaCloud Technology (GCT) Narrative Is Evolving After Q4 Beats And Higher TargetsFollowing a robust fourth-quarter earnings report, the narrative surrounding GigaCloud Technology Inc. is shifting as financial analysts revise their outlooks upward. The primary focus is a notable...
April 18, 2026 - 09:11
Is It Too Late To Consider Microchip Technology (MCHP) After A 110% One Year Surge?Investors are closely examining Microchip Technology following a staggering one-year share price surge of over 110%. The stock`s remarkable performance, including a 21% gain year-to-date,...
April 17, 2026 - 23:14
Micron Technology Is Helping the Market’s Hottest Value ETF Crush the MarketA prominent value-focused exchange-traded fund is significantly outperforming the broader market, driven by substantial holdings in key semiconductor and technology hardware companies. The iShares...